Englishعربي
HomePet SuppliesDogsHealth SuppliesInsect Repellent1400mg Fluralaner Anti-Flea & Tick Chewable Tablets for XL Dogs (40-56kg)1 tablets
product_image_name-Bravecto-1400mg Fluralaner Anti-Flea & Tick Chewable Tablets for XL Dogs (40-56kg)1 tablets-1

Share this product

Bravecto 1400mg Fluralaner Anti-Flea & Tick Chewable Tablets for XL Dogs (40-56kg)1 tablets

EGP 3,300.00
EGP 4,000.0018%

3 units left

Free delivery to 6th of October
0 out of 5
(No ratings available)

Promotions

Delivery & Returns

Choose your location

Pickup Station

Free delivery
Ready for pickup between 09 March and 11 March if you place your order within the next 13hrs 44mins

Door Delivery

Delivery Fees EGP 35.00
Ready for delivery between 09 March and 11 March if you place your order within the next 13hrs 44mins

Return Policy

You can return your item for free within 14 days of delivery if it is eligible. Any visible defects must be reported within 48 hours. Check our return policy forDetails

Seller Information

dog zone

64%Seller Score

14 Followers

Follow

Seller Performance

Shipping speed: Average

Quality Score: Poor

Customer Rating: Excellent

Product details

Bravecto 1400mg Fluralaner is a chewable tablet designed for extra-large dogs (40–56 kg). It provides effective protection against fleas and ticks for up to 12 weeks with just a single dose. The tablet is easy to administer and well-accepted by most dogs due to its palatable flavor.

Specifications

Key Features

Long-lasting protection against fleas and ticks (up to 12 weeks).

Suitable for extra-large dogs weighing 40–56 kg.

Single-dose, easy-to-administer chewable tablet.

Vet-recommended and clinically proven.

Tasty flavor that dogs love.

Specifications

  • SKU: BR090LS2643WLNAFAMZ

Verified Customer Feedback

This product has no ratings yet.

Bravecto 1400mg Fluralaner Anti-Flea & Tick Chewable Tablets for XL Dogs (40-56kg)1 tablets

Bravecto 1400mg Fluralaner Anti-Flea & Tick Chewable Tablets for XL Dogs (40-56kg)1 tablets

EGP 3,300.00
EGP 4,000.0018%

Recently Viewed

See All